. Author manuscript; available in PMC: 2020 Nov 1.

Published in final edited form as: Urol Oncol. 2019 Sep 12;37(11):811.e9–811.e16. doi: 10.1016/j.urolonc.2019.07.011

Table 3.

Overall survival: multivariate analysis

N=79	HR	95% CI	p-value
Pathological tumor stage			0.052
≤T2	Ref.
≥T3	1.91	0.97 – 3.74
Sarcomatoid differentiation			0.014
Absent	Ref.
Present	2.18	1.19 – 3.97
Papillary Features			<0.001
Absent	Ref.
Present	0.37	0.21 – 0.65
NLR	1.27	1.14 – 1.40	<0.001